Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Pharmacokinetics and therapeutic efficacy were investigated in patients with multiple myeloma receiving both generic and innovator melphalan (MEL) formulation for conditioning pre autologous stem cell transplantation. Both the MEL formulations were comparable in terms of pharmacokinetics and efficac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Lymphoma Myeloma Leuk
Asıl Yazarlar: Pai, Aswin Anand, Devasia, Anup J., Panetta, John Carl, Mani, Sathya, Illangeswaran, Raveen Stephen Stallon, Mohanan, Ezhilpavai, Balakrishnan, Balaji, Lakshmi, Kavitha M., Kulkarni, Uday, Aboobacker, Fouzia N., Korula, Anu, Abraham, Aby, Srivastava, Alok, Mathews, Vikram, George, Biju, Balasubramanian, Poonkuzhali
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115908/
https://ncbi.nlm.nih.gov/pubmed/31791694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.08.013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller